European Medicines Agency Accepts Hetlioz Marketing Authorization Application
Vanda Pharmaceuticals Inc’s Marketing Authorization Application (MAA) for oral Hetlioz (tasimelteon) capsules has been accepted for evaluation by the European Medicines Agency (EMA) for the treatment of Non-24-Hour...
Read More